Skip to main content

Table 2 Characteristics of sentinel lymph node(s), total and by study site

From: Retrospective validation study of an artificial neural network-based preoperative decision-support tool for noninvasive lymph node staging (NILS) in women with primary breast cancer (ISRCTN14341750)

 

Total

Site 1

Site 2

 

Count

%

Count

%

Count

%

p value*

Number of extracted SLN(s)

1

158

27.0%

90

22.8%

68

35.6%

 < 0.001

2

198

33.8%

124

31.4%

74

38.7%

3 + 

230

39.2%

181

45.8%

49

25.7%

Metastases in SLN

No

432

73.7%

293

74.2%

139

72.8%

0.718

Yes

154

26.3%

102

25.8%

52

27.2%

Number of metastases in SLN(s)

1

108

70.1%

68

66.7%

40

76.9%

0.313

2

33

21.4%

25

24.5%

8

15.4%

3

10

6.5%

6

5.9%

4

7.7%

4

3

1.9%

3

2.9%

0

0.0%

Size largest SLN-metastasis (mm), mean (range)

5.2 (0.2—38.0)

5.1 (0.2—38.0)

5.3 (0.3—26.0)

0.857

SLN metastases, categorized

No metastases

432

73.7%

293

74.2%

139

72.8%

0.928

Micro: > 0.2 mm, ≤ 2 mm

64

10.9%

42

10.6%

22

11.5%

Macro: > 2 mm

90

15.4%

60

15.2%

30

15.7%

  1. *For categorical variables, Chi-squared test was used and for continuous variables, t-test was used
  2. Abbreviations: SLN Sentinel lymph node